AzTrials
AzTrials

Maternal MortalityNCT06134518

Effectiveness of the Education Program on Increasing the Competency Level of Health Cadres in Indonesia

A study testing The education program and the initial orientation from the PHCs in people with Maternal Mortality, run by Hiroshima University at 1 site in Indonesia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Ending preventable maternal mortality (EPMM): By 2030, every country should reduce its maternal mortality ratio (MMR) by at least two-thirds from the 2010 baseline. In the era of the SDGs, an acceleration of current progress is required to achieve SGD target 3.1, working towards a vision of ending all preventable… Read more about this study

Who is it for?
Ages 19 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Maternal Mortality
What is being tested?
The education program and the initial orientation from the PHCs
Could I receive a placebo?
No, everyone receives an active treatment
How many people
133 participants
Where
1 siteIndonesia
Study dates
30 Nov 2023to 17 Feb 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Currently working as a health care for at least 1 year
  • Domiciled in the local area
  • Able to operate a telephone
  • Those who agreed to give consent and are willing to participate in the study
  • Those who agreed to receive the health education program and participate in the whole evaluation process.

Who cannot join

  • Those who are planning to move out to another city during the study period.
  • Those who are no longer work as a health cadre.

Trial locations and contacts

1 site in 1 country.

Indonesia1 site
  • Politeknik Banjarnegara

    Banjarnegara, Cental Java, 53482

Other trials in Indonesia

About this study

Ending preventable maternal mortality (EPMM): By 2030, every country should reduce its maternal mortality ratio (MMR) by at least two-thirds from the 2010 baseline. In the era of the SDGs, an acceleration of current progress is required to achieve SGD target 3.1, working towards a vision of ending all preventable maternal mortality. In Central Java, one of the most effective efforts to reduce maternal mortality is increasing the number of human resources, who can assist pregnant mothers and supervise their period of pregnancy. The maternal mortality rate (MMR) in Banjarnegara Regency in 2021 is 287.05 per 100,000 live births, this indicates the top 10 in Central Java Province over the past 5 years. Health cadres, who are non-professional volunteer health supporters for pregnant women appointed by regional public health centers (PHCs), are expected to be the key human resources who contribute to reducing MMR in Indonesia and Banjarnegara Regency as well. However, based on an initial study by researchers conducting qualitative research with focus group discussions (FGDs) and in-depth interviews in April-July 2023, researchers found that health cadres had incorrect and unscientific knowledge. Therefore, improving the knowledge and skills of the health cadres through education programs could be expected to further improve the health outcomes of pregnant women, consequently contributing to reducing the MMR.

The purpose of this study is to improve health cadres' competency level in monitoring the risks of pregnant women. This monitoring activities for pregnant women by cadres is an effort to prevent maternal mortality, because if there are complications they can be treated as early as possible.

Read the detailed description
  1. Prior to the commencement of the study, the PI will visit the selected PHCs as the intervention group and control group, and then explain an overview of this study. The PI obtained the agreement to participate in this study from the head of the PHC.
  2. The PI will ask the coordinator midwife at each PHC to introduce the names and phone numbers of the health cadres who will be potential participants. The PI and the researchers will contact each potential participant one by one to explain the procedure of this study and then obtain their consent to become a participant in this study. Cadres who belong to PHCs will receive the competency-based education program, and those who belong to PHCs allocated to the control group will follow the initial orientation provided by the PHC.
  3. The PI and assistant (research team) will create a WhatsApp group for the intervention group and control group, and then distribute the questionnaires at an initial stage. All data will be collected at each PHC where the study will be conducted.
Being tested
The education program, the initial orientation from the PHCs
Keywords
competency level, health cadre, maternal mortality
Medical subject headings
Maternal Death

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The education programOther

    The intervention group will receive the competency-based education program for 1 month at each PHC, after baseline data collection. The education program will be conducted weekly. This education session will be conducted for 4 hours per session, with 20 health cadres in a group per PHC. The competency level is measured by the researcher developing a competency questionnaire which consists of a knowledge test, skill, and attitude checklist score at the 2nd post-assessment (2 months after being given the education program).

  • the initial orientation from the PHCsOther

    the initial orientation from the PHCs

Study groups in NCT06134518
Study groupRoleWhat they receive
interventionExperimentalThe intervention group will receive the competency-based education program for 1 month at each PHC, after baseline data collection. The education program will be conducted weekly. This education session will be conducted for 4 hours per session, with 20 health cadres in a group per PHC .The competency level is measured by the researcher developing a competency questionnaire which consists of a knowledge test, skill, and attitude checklist score at the 2nd post-assessment (2 months after being given the education program).
Receives: Other: The education program
controlExperimentalHealth cadres in the control group have received the initial orientation from the PHCs. In this study, they take only the competency questionnaires including skill check will be collected following the data collection timeline. After completing the research, the control group will receive the education program material used for the intervention group if they require.
Receives: Other: the initial orientation from the PHCs

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The competency level of health cadres

    Competency is operationally defined as the ability to integrate components of knowledge, skills, values, and attitudes into practice, and build a trusting relationship with and guide a pregnant woman and her surroundings for them to take evidence-based appropriate behavior. The competency level is measured by the researcher developing a competency questionnaire which consists of a knowledge test, skill, and attitude checklist score

    Measured: baseline (T0), after 1 month from the baseline (T1) and after 3 months from the baseline (T2)

Secondary outcomes (5)
  1. The knowledge test scores of health cadres

    researcher developing knowledge questionnaire

    Measured: baseline (T0), after 1 month from the baseline (T1) and after 3 months from the baseline (T2)

  2. The health assessment skills checklist score of health cadres

    researcher developing health assessment skills checklist

    Measured: after 1 month from the baseline (T1) and after 3 months from the baseline (T2)

  3. The communication skills checklist score of health cadres

    researcher developing communication skills checklist

    Measured: after 1 month from the baseline (T1) and after 3 months from the baseline (T2)

  4. The confidence score of health cadres

    researcher developing communication skills checklist

    Measured: after 1 month from the baseline (T1) and after 3 months from the baseline (T2)

  5. The satisfaction score of health cadres

    researcher developing satisfaction skills checklist

    Measured: after 1 month from the baseline (T1)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Nov 2023
  2. Study start30 Nov 2023
  3. Primary completion5 Dec 2023
  4. Study completion17 Feb 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Intervention group control group
Masking
None (open label)
Enrolment
133 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06134518
Sponsor's protocol ID
550/EA/KEPK-FKM/2023
Status last verified
Sep 2024
First submitted
12 Nov 2023
Last updated
19 Sep 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Share according to request to the PI and researcher

Publications

  • Sulistyorini D, Huq KATME, Babaita AO, Aivey SA, Huiying G, Kazawa K, Fukushima Y, Kako M, Moriyama M. Effectiveness of education programme to increase competency of health cadres in Indonesia: a cluster non-randomised controlled trial. BMJ Open. 2025 Dec 29;15(12):e095428. doi: 10.1136/bmjopen-2024-095428.

    PubMed 41469067

Questions about this trial

What is this clinical trial studying?

A study testing The education program and the initial orientation from the PHCs in people with Maternal Mortality, run by Hiroshima University at 1 site in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The competency level of health cadres (time frame: baseline (T0), after 1 month from the baseline (T1) and after 3 months from the baseline (T2)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06134518, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in